Product NDC: | 0378-1430 |
Proprietary Name: | Nicardipine Hydrochloride |
Non Proprietary Name: | nicardipine hydrochloride |
Active Ingredient(s): | 30 mg/1 & nbsp; nicardipine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-1430 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074642 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110617 |
Package NDC: | 0378-1430-77 |
Package Description: | 90 CAPSULE in 1 BOTTLE, PLASTIC (0378-1430-77) |
NDC Code | 0378-1430-77 |
Proprietary Name | Nicardipine Hydrochloride |
Package Description | 90 CAPSULE in 1 BOTTLE, PLASTIC (0378-1430-77) |
Product NDC | 0378-1430 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | nicardipine hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20110617 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | NICARDIPINE HYDROCHLORIDE |
Strength Number | 30 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |